EX-99.1 2 dex991.htm PRESS RELEASE Press Release

Exhibit 99.1

Nanophase Reports Second Quarter 2009 Financial Results

Nanophase Continues to Execute New Strategy

Romeoville, IL,—August 4, 2009—Nanophase Technologies Corporation (Nasdaq: NANX), a technology leader in nanomaterials and advanced nanoengineered products, reported today financial results for its second quarter ending June 30, 2009.

Second Quarter

Revenue for second quarter 2009 was $1.6 million, compared to $2.9 million for the same period in 2008. The net loss for the quarter was $1.2 million, or $0.06 per share, compared to a net loss of $0.8 million, or $0.04 per share, for the second quarter of 2008.

Jess Jankowski, President and CEO of Nanophase, noted, “Although results were below prior year, they were in-line with expectations. The results reinforce our view that we must successfully transition Nanophase to a market-driven business model that has a diverse base of customers and revenue streams, while concurrently managing our costs to help off-set the decline in revenue.”

Looking Ahead

“The last several months have shown some solid business development and destocking of excess inventory has started to reverse, both with some of our own customers and industry wide. We believe this shift is and will be a positive one for Nanophase,” said Jankowski.

“Over the past year we have aligned around several market segments, allowing us to better leverage our activities. The quality and quantity of these opportunities continues to improve, as does our eventual ability to convert these opportunities into revenue for Nanophase. This is a direct result of us focusing on fewer markets and building a stronger understanding of the performance benefits of our products in each of those markets.

“While transition costs obscured the benefits in our first half 2009 results, we have reduced our annual expense rate by $2 million, despite increasing the number of business opportunities we have been actively pursuing. This realignment along a lean structure should become even more apparent as we continue through 2009, and is already reflected in a meaningful reduction in sales, general & administrative expenses compared with 2008.” He noted SG&A in second quarter 2009 was $1.05 million, down 31% from second quarter 2008, while first half 2009 SG&A was $2.05 million compared with $3.10 million in first half 2008. “We are spending money prudently, and expect to generate future savings due to the philosophy accompanying these changes.”

Jankowski concluded: “Our research and development efforts are well aligned with the market-driven, direct-to-the-customer model. In addition to continuing to serve the needs of our existing partners, we are intent on building applications expertise in carefully selected market segments. We are tailoring our product offerings towards customers’ identified unmet needs where there is a strong value proposition. We continue to develop ready-to-go products that should serve the customers’ needs more directly. We expect the prospects for success will be improved relative to our previous model. We believe we are doing the right things to build the business.”


Shareholders and members of the investing community are encouraged to participate in today’s conference call, where Jankowski will be discussing the company’s second quarter performance and 2009 prospects.

2nd Quarter Conference Call

Nanophase has scheduled its quarterly conference call for August 4, 2009, at 4:00 p.m. CDT (5:00 p.m. EDT), which will be hosted by Jess Jankowski, president and CEO. To participate in the call you may dial 800-344-8034, or 785-830-1990 and reference the conference identification of 7NANOPHASE. The call may also be accessed through the company’s website, www.nanophase.com, by clicking on the link under News Center and Calendar of Events. If you are unable to attend, a replay will be available through August 11, 2009, by dialing 800-723-0544, or 402-220-2656, or by logging onto the company’s website and following the above directions.

Use of Non-GAAP Financial Information

Nanophase believes that the presentation of results excluding certain items, including severance charges and non-cash equity compensation charges, provides meaningful supplemental information to both management and investors, facilitating the evaluation of performance across reporting periods. The Company uses these non-GAAP measures for internal planning and reporting purposes. These non-GAAP measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP measures used by other companies. The presentation of this additional information is not meant to be considered in isolation or as a substitute for net income or net income per share prepared in accordance with generally accepted accounting principles.

About Nanophase Technologies

Nanophase Technologies Corporation (NANX), www.nanophase.com, is a leader in nanomaterials technologies and provides nanoengineered solutions for multiple industrial product applications. Using a platform of patented and proprietary integrated nanomaterial technologies, the Company creates products with unique performance attributes from two ISO 9001:2000 and ISO 14001 facilities. Nanophase delivers commercial quantity and quality nanoparticles, coated nanoparticles, and nanoparticle dispersions in a variety of media.

Forward-Looking Statements

This press release contains words such as “expects,” “shall,” “will,” , “believes,” and similar expressions that are intended to identify forward-looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Such statements in this announcement are made based on the Company’s current beliefs, known events and circumstances at the time of publication, and as such, are subject in the future to unforeseen risks and uncertainties that could cause the Company’s results of operations, performance and achievements to differ materially from current expectations expressed in, or implied by, these forward-looking statements. These risks and uncertainties include, without limitation, the following: a decision by a customer to cancel a purchase order or supply agreement in light of the Company’s dependence on a limited number of key customers; uncertain demand for, and acceptance of, the Company’s nanocrystalline materials; the Company’s manufacturing capacity and product mix flexibility in light of customer demand; the Company’s limited marketing experience; changes in development and distribution relationships; the impact of competitive products and technologies; the Company’s dependence on patents and protection of proprietary information; the resolution of litigation in which the Company may become involved; and other factors described in the Company’s Form 10-K filed March 25, 2009. In addition, the Company’s forward-looking statements could be affected by general industry and market conditions and growth rates. Except as required by federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events, uncertainties or other contingencies.


NANOPHASE TECHNOLOGIES CORPORATION

BALANCE SHEETS

(Unaudited)

 

ASSETS    June 30,
2009
    December 31,
2008
 

Current assets:

    

Cash and cash equivalents

   $ 649,546      $ 723,069   

Investments

     3,664,418        6,908,888   

Trade accounts receivable, less allowance for doubtful accounts of $9,000 on June 30, 2009 and December 31, 2008

     916,389        1,092,125   

Other receivable

     —          7,749   

Inventories, net

     1,095,395        1,154,207   

Prepaid expenses and other current assets

     436,346        482,452   
                

Total current assets

     6,762,094        10,368,490   

Investments

     5,340,000        5,340,000   

Equipment and leasehold improvements, net

     6,073,015        6,651,842   

Other assets, net

     39,872        39,765   
                
   $ 18,214,981      $ 22,400,097   
                

LIABILITIES AND STOCKHOLDERS’ EQUITY

    

Current liabilities:

    

Current portion of capital lease obligations

     8,089        22,211   

Current portion of deferred other revenue

     10,608        74,243   

Current portion of long term debt, less current maturities and debt discount

     530,702        1,570,346   

Accounts payable

     424,248        356,853   

Accrued expenses

     1,445,641        1,493,262   

Accrued severance

     375,172        541,014   
                

Total current liabilities

     2,794,460        4,057,929   
                

Long-term portion of capital lease obligations

     5,081        9,219   
                
     5,081        9,219   
                

Contingent liabilities:

     —          —     

Stockholders’ equity:

    

Preferred stock, $.01 par value, 24,088 shares authorized and no shares issued and outstanding

     —          —     

Common stock, $.01 par value, 30,000,000 shares authorized; 21,204,162 and 21,188,912 shares issued and outstanding on June 30, 2009 and December 31, 2008, respectively

     212,042        211,889   

Additional paid-in capital

     92,027,075        91,597,529   

Accumulated deficit

     (76,823,677     (73,476,469
                

Total stockholders’ equity

     15,415,440        18,332,949   
                
   $ 18,214,981      $ 22,400,097   
                


NANOPHASE TECHNOLOGIES CORPORATION

STATEMENTS OF OPERATIONS

(Unaudited)

 

       Three months ended
June 30,
     Six months ended
June 30,
 
       2009      As Adjusted
2008
     2009      As Adjusted
2008
 

Revenue:

             

Product revenue, net

     $ 1,500,733       $ 2,811,626       $ 2,797,546       $ 5,754,347   

Other revenue

       109,930         132,780         218,275         244,167   
                                     

Total revenue

       1,610,663         2,944,406         3,015,821         5,998,514   

Operating expense:

             

Cost of revenue

       1,430,363         1,836,276         2,745,287         3,836,484   
                                     

Gross Profit

       180,300         1,108,130         270,534         2,162,030   

Research and development expense

       381,075         416,239         785,119         854,934   

Selling, general and administrative expense

       1,051,343         1,529,643         2,051,510         3,104,387   

Severance charges

       —           —           794,069      
                                     

Loss from operations

       (1,252,118      (837,752      (3,360,164      (1,797,291

Interest income

       24,291         80,788         58,294         248,010   

Interest expense

       (12,379      (33,142      (33,286      (71,559

Other, net

       1,652         (2,074      (12,052      157   
                                     

Loss before provision for income taxes

       (1,238,554      (792,180      (3,347,208      (1,620,683

Provision for income taxes

       —           —           —           —     
                                     

Net loss

     $ (1,238,554    $ (792,180    $ (3,347,208    $ (1,620,683
                                     

Net loss per share—basic and diluted

     $ (0.06    $ (0.04    $ (0.16    $ (0.08
                                     

Weighted average number of common shares outstanding

       21,204,162         21,130,697         21,200,791         21,118,652   
                                     


NANOPHASE TECHNOLOGIES CORPORATION

STATEMENTS OF OPERATIONS—EXPANDED SCHEDULE

(Unaudited)

 

     Three months ended June 30,     Six months ended June 30,  
     2009     As Adjusted
2008
    2009     As Adjusted
2008
 

Revenue:

        

Product revenue, net

   $ 1,500,733      $ 2,811,626      $ 2,797,546      $ 5,754,347   

Other revenue

     109,930        132,780        218,275        244,167   
                                

Total revenue

     1,610,663        2,944,406        3,015,821        5,998,514   

Operating expense:

        

Cost of revenue detail:

        

Depreciation

     226,692        240,575        486,068        478,620   

Non-Cash equity compensation

     18,073        20,165        26,416        36,936   

Other costs of revenue

     1,185,598        1,575,536        2,232,803        3,320,928   
                                

Cost of revenue

     1,430,363        1,836,276        2,745,287        3,836,484   
                                

Gross profit

     180,300        1,108,130        270,534        2,162,030   

Research and development expense detail:

        

Depreciation

     57,227        59,318        114,270        117,775   

Non-Cash equity compensation

     25,748        38,281        48,022        69,313   

Other research and development expense

     298,100        318,640        622,827        667,846   
                                

Research and development expense

     381,075        416,239        785,119        854,934   

Selling, general and administrative expense detail:

        

Depreciation and amortization

     19,385        15,154        39,727        29,705   

Non-Cash equity compensation

     81,664        173,682        156,433        326,342   

Trademark abandonment charge

     —          —          —          37,214   

Other selling, general and administrative expense

     950,294        1,340,807        1,855,350        2,711,126   
                                

Selling, general and administrative expense

     1,051,343        1,529,643        2,051,510        3,104,387   

Severance charges

     —          —          794,069        —     
                                

Loss from operations

     (1,252,118     (837,752     (3,360,164     (1,797,291

Interest income

     24,291        80,788        58,294        248,010   

Interest expense

     (12,379     (33,142     (33,286     (71,559

Other, net

     1,652        (2,074     (12,052     157   
                                

Loss before provision for income taxes

     (1,238,554     (792,180     (3,347,208     (1,620,683

Provision for income taxes

     —          —          —          —     
                                

Net loss

   $ (1,238,554   $ (792,180   $ (3,347,208   $ (1,620,683
                                

Non-GAAP Disclosure (see note regarding Non-GAAP disclosures):

        

Addback Interest, net

     (11,912     (47,646     (25,008     (176,451

Addback Depreciation/Amortization

     303,304        315,047        640,065        626,100   

Addback Severance Charge

     —          —          794,069        —     

Addback Non-Cash Equity Compensation

     125,485        232,128        230,871        432,591   
                                

Adjusted EBITDA

   $ (821,677   $ (292,651   $ (1,707,211   $ (738,443